Dr. Waples is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 Cci Dr Nw
Huntsville, AL 35805Phone+1 256-705-4224Fax+1 256-705-4135- Is this information wrong?
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of FloridaResidency, Internal Medicine, 1992 - 1995
- University of Florida College of MedicineClass of 1992
Certifications & Licensure
- AL State Medical License 1998 - 2024
- TN State Medical License 2013 - 2016
- FL State Medical License 1994 - 2000
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma Start of enrollment: 2003 Oct 01
- Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) Start of enrollment: 2004 Feb 01
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 7 citationsA phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.Bradley J. G. Larson, John M. Waples, Annette Pusateri, Nancy P. Mendenhall, James W. Lynch> ;American Journal of Clinical Oncology. 2005 Apr 1
- 19 citationsManagement of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant.Marc Zumberg, John M. Waples, K.J. Kao, Richard Lottenberg> ;American Journal of Hematology. 2000 May 1
- A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyelo...Hesketh, P. J., Arena, F., Patel, D., Austin, M., D'Avirro, P., Rossi, G., Colowick, A., Schwartzberg, L., Bertoli, L. F., Cole, J. T., Demetri, G., Dessypris, E., Dob...> ;Cancer. 2004 Feb 15
- Join now to see all
Press Mentions
- OneOncology Partners With Huntsville's Clearview Cancer InstituteJanuary 17th, 2024
Hospital Affiliations
- Huntsville HospitalHuntsville, Alabama
- Hill Hospital of Sumter CountyYork, Alabama
- Crestwood Medical CenterHuntsville, Alabama
- Decatur Morgan HospitalDecatur, Alabama
- Birmingham VA Medical CenterBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: